Edition:
United States

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.19USD
3:59pm EST
Change (% chg)

$0.05 (+4.39%)
Prev Close
$1.14
Open
$1.15
Day's High
$1.21
Day's Low
$1.12
Volume
48,168
Avg. Vol
59,576
52-wk High
$6.89
52-wk Low
$0.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.232
Jun '17 0.00 -0.216
Mar '17 0.00 -0.294
FY 2016 Dec '16 0.00 -0.229
Sep '16 0.00 -0.285
Jun '16 0.00 -0.350
Mar '16 0.00 -0.338
FY 2015 Dec '15 0.00 -0.199
Sep '15 0.00 -0.661
Jun '15 0.00 -0.244
Mar '15 0.00 -0.359
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 0.00 0.00 0.00 0.00
Year Ending Dec-17 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 26.77
Earnings (per share)
Quarter Ending Dec-17 3 -0.18 -0.16 -0.22 -0.35
Quarter Ending Mar-18 1 -0.16 -0.16 -0.16 --
Year Ending Dec-17 3 -0.87 -0.85 -0.90 -1.28
Year Ending Dec-18 3 -0.74 -0.63 -0.90 -1.04
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.50 35.37
P/E High - Last 5 Yrs. -- 275.44 45.18
P/E Low - Last 5 Yrs. -- 92.47 24.20
Beta 0.42 0.82 0.91
Price to Sales (TTM) -- 113.76 5.84
Price to Book (MRQ) 4.19 21.88 5.65
Price to Tangible Book (MRQ) 6.70 25.71 7.25
Price to Cash Flow (TTM) -- 102.10 24.30
% Owned Institutions 17.01 5.62 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 97.35 46.04

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.12 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.10 5.63
Sales - 5 Yr. Growth Rate -- 33.18 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.65 -148.25 7.98
EPS (TTM) vs TTM 1 Yr. Ago 17.18 -- --
EPS - 5 Yr. Growth Rate -- 43.65 10.92
Capital Spending - 5 Yr. Growth Rate -5.22 40.96 15.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 2.32 5.70 3.56
LT Debt to Equity (MRQ) 0.00 14.49 13.37
Total Debt to Equity (MRQ) 0.00 16.95 19.40
Interest Coverage (TTM) -1,475.37 -138.10 44.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.91 54.89
Gross Margin - 5 Yr. Avg. -- 55.68 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.89 15.52
Operating Margin (TTM) -- -626.98 6.76
Operating Margin - 5 Yr. Avg. -- -232.77 11.02
Pre-Tax Margin (TTM) -- -597.81 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -233.06 11.42
Net Profit Margin (TTM) -- -595.34 3.81
Net Profit Margin - 5 Yr. Avg. -- -236.34 7.71
Effective Tax Rate (TTM) -- 15.36 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.92 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,716,698 852,152,758
Net Income/Employee (TTM) -1,501,583 -1,723,651 99,529,045
Receivable Turnover (TTM) -- 26.31 6.14
Inventory Turnover (TTM) -- 2.63 3.55
Asset Turnover (TTM) 0.00 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -110.41 -9.30 11.32
Return on Assets - 5 Yr. Avg. -91.25 0.22 12.29
Return on Investment (TTM) -136.18 -11.67 14.45
Return on Investment - 5 Yr. Avg. -103.34 3.35 16.09
Return on Equity (TTM) -136.18 -36.21 16.05
Return on Equity - 5 Yr. Avg. -109.36 5.77 17.30
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 15.98 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aevi Genomic Medicine Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.01%
# of Holders: 64
Total Shares Held: 10,090,009
3 Mo. Net Change: 2,240,174
# New Positions: 7
# Closed Positions: 13
# Increased Positions: 19
# Reduced Positions: 26
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.